REXAHN PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Non-Exclusive License Agreement between The Trustees of the University of Pennsylvania and Opus Genetics, Inc. (March 2, 2023)
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
PA
2025
Amended and Restated License Agreement between The Trustees of the University of Pennsylvania and Opus Genetics Inc.
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
PA
2025
Amendment No. 4 to Exclusive License Agreement with Know-How among University of Pennsylvania, University of Florida Research Foundation, and Opus Genetics Inc.
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 2 to Exclusive License Agreement with Know-How among University of Pennsylvania, University of Florida Research Foundation, and IVERIC Bio Gene Therapy LLC
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 1 to Exclusive License Agreement with Know-How among University of Pennsylvania, University of Florida Research Foundation, and IVERIC bio, Inc.
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Exclusive License Agreement with Know-How among University of Pennsylvania, University of Florida Research Foundation, and Ophthotech Corporation (April 10, 2019)
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
PA
2025
License and Collaboration Agreement between Ocuphire Pharma Inc. and FamyGen Life Sciences, Inc.
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2022
License Agreement between Processa Pharmaceuticals, Inc. and Ocuphire Pharma, Inc. dated June 16, 2021
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MD
2021
Sublicense Agreement between Apexian Pharmaceuticals, Inc. and Ocuphire Pharma, Inc. (January 21, 2020)
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MI
2020
Collaboration and License Agreement between Biosense Global LLC and Rexahn Pharmaceuticals, Inc. (RX-3117)
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Amendment No. 2 to Research and Exclusive License Option Agreement between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2012
Amendment No. 1 to Research and Exclusive License Option Agreement between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2011
Research and Exclusive License Option Agreement between Teva Pharmaceutical Industries Limited and Rexahn Pharmaceuticals, Inc.
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2009
Research and Exclusive License Option Agreement between Rexahn Pharmaceuticals, Inc. and [Counterparty]
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2009